Research Letter

Accuracy of Self-Selection for Medication Abortion Using a Prototype Drug Facts Label

JAMA Internal Medicine 10.1001/jamainternmed.2026.0298

April 06, 2026 at 11:00 AM EDT

Read the full article

This diagnostic study examines whether patients seeking an abortion could accurately self-select their eligibility to use over-the-counter (OTC) medication abortion by using a prototype OTC package and drug facts label.

Corresponding Author: Lauren Ralph, PhD, MPH, Advancing New Standards in Reproductive Health (ANSIRH), Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, 1330 Broadway, Suite 1100, Oakland, CA 94612 (lauren.ralph@ucsf.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks